Skip to main content
. 2020 Sep 1;11(10):2341–2355. doi: 10.1007/s13300-020-00906-x

Table 3.

Comparison of anthropometric and body composition measurements and biochemical parameters between the two groups

Variables Intervention group
(n = 57)
P1 Control group
(n = 43)
P2 Changes between the two groups (95% CI) P value (intervention vs. control)
Before After Before After
Weight (kg) 67.8 ± 11.7 65.6 ± 11.7 < 0.001 66.4 ± 15.7 65.6 ± 16.3 0.030 − 1.4 (− 2.2, − 0.6) 0.001
BMI (kg/m2) 25.5 ± 2.9 24.8 ± 2.9 < 0.001 25.2 ± 4.0 25.0 ± 4.3 0.228 − 0.5 (− 0.9, − 0.2) 0.006
Skeletal muscle mass(kg) 24.6 ± 6.0 24.5 ± 6.0 0.484 24.3 ± 6.2 24.1 ± 6.2 0.062 0.1 (− 0.2, 0.5) 0.437
Body fat mass (kg) 22.7 ± 5.4 20.8 ± 5.5 < 0.001 21.8 ± 7.7 21.5 ± 8.3 0.372 − 1.6 (− 2.4, − 0.8) < 0.001
Percentage body fat (%) 33.7 ± 6.2 31.9 ± 6.6 < 0.001 32.5 ± 6.8 32.3 ± 6.6 0.738 − 1.7 (− 2.6, − 0.7) 0.001
Visceral fat area (cm2) 111.6 ± 30.1 101.7 ± 30.7 < 0.001 105.4 ± 40.2 104.7 ± 42.2 0.654 − 9.1 (− 13.9, − 4.4) < 0.001
Fasting plasma glucose(mmol/l) 5.66 ± 0.56 5.46 ± 0.68 0.003 5.58 ± 0.62 5.40 ± 0.66 0.029 − 0.02 (− 2.22, 0.18) 0.845
HbA1c (%) 6.00 ± 0.39 5.77 ± 0.34 < 0.001 6.06 ± 0.40 5.93 ± 0.41 0.007 − 0.10 (− 0.22, 0.03) 0.120
Triglycerides(mmol/l) 1.78 ± 1.26 1.40 ± 0.69 0.004 1.77 ± 1.47 1.76 ± 1.56 0.902 − 0.36 (− 0.68, − 0.04) 0.029
Total cholesterol (mmol/l) 5.54 ± 1.18 5.40 ± 1.02 0.040 5.53 ± 1.02 5.49 ± 1.02 0.746 − 0.10 (− 0.39, 0.18) 0.472
HDL‐cholesterol (mmol/l) 1.43 ± 0.32 1.31 ± 0.28 < 0.001 1.49 ± 0.34 1.31 ± 0.26 < 0.001 0.06 (− 0.03, 0.14) 0.177
LDL‐cholesterol (mmol/l) 3.30 ± 1.13 3.45 ± 0.96 0.033 3.37 ± 0.84 3.37 ± 1.05 0.997 0.15 (− 0.11,0.41) 0.243

BMI body mass index, HbA1c glycated hemoglobin, HDL-cholesterol high-density lipoprotein cholesterol, LDL cholesterol low-density lipoprotein cholesterol, P1 P value before and after intervention in the intervention group, P2 P value before and after intervention in the control group